If l took a guess at our program it would be Phase 2 results being filtering in over the next 4/12 months, if the results are as predicted or close to. That would put us in a position to be exploring licensing agreements follows by injections of funds from them and then commercialisation, l believe with the results from Phase 1 it unlikely the FDA will request us to engage in Phase 3. l think we are looking good at this stage with our patients and investments.
Add to My Watchlist
What is My Watchlist?
